Key points are not available for this paper at this time.
A 68-year-old man presents with newly diagnosed prostate cancer. Over the past 3 years, his prostate-specific antigen level has slowly and steadily increased. His digital rectal examination is normal, the estimated prostate volume is 48 ml, and a needle-biopsy specimen reveals an adenocarcinoma with a Gleason score of 6 involving 10% of 1 of the 12 cores. He otherwise is well. How should his case be managed?
Walsh et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: